P. Griffin

发表

Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes.

W. James, C. Rider, J. Ibrahim, 1999, Virus research.

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

David A. Price, A. Wood, P. Dorr, 2005, Antimicrobial Agents and Chemotherapy.

CCR 5 Signaling Assays and Application to Quantify and Characterize Ligand-Dependent Agonism , Antagonism , and Inverse Agonism

I. Navratilova, P. Dorr, M. Perros, 2009 .

CCR5 pharmacology methodologies and associated applications.

I. Navratilova, P. Dorr, M. Perros, 2009, Methods in enzymology.

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

David A. Price, A. Wood, P. Dorr, 2005, Antimicrobial Agents and Chemotherapy.

Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site.

N. Proudfoot, W. James, M. Ashe, 1995, Genes & development.

Requirements for Hirano Body Formation

M. Fechheimer, R. Furukawa, P. Griffin, 2014, Eukaryotic Cell.

Characterization of the interactions of the Dictyostelium 34 kDa actin-bundling protein with actin filaments and the requirements for formation of Hirano bodies

P. Griffin, 2010 .

New Small-Molecule Inhibitor Class Targeting Human Immunodeficiency Virus Type 1 Virion Maturation

S. Butler, W. Blair, A. Patick, 2009, Antimicrobial Agents and Chemotherapy.

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding.

I. De Clercq, A. Steinkasserer, W. James, 1996, Antiviral research.